TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
XGN

Exagen Inc

Healthcare · Diagnostics & Research

8.40$ +6.9% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Cash Flow

Exagen Inc (XGN) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -14 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow XGN
Line item 2013 2014 2015 2017 2018 2019 2020 2021 2022 2023 2024 2025
-6.9 -11 -12 -11 -9.3 -9.7 -14 -20 -32 -14 -13 -14
0.5 0.6 0.9 0.7 0.7 0.6 0.5 0.9 1.6 2.2 1.7 2.1
0.2 0.3 0.3 0.2 0.1 0.6 2.7 4.7 4.7 3.6 1.8 2.2
1.3 5.8 16 1.0 0.9 3.1 5.4 12
0.8 1.7 -0.9 -2.0 -3.6 0.2 -1.3 -0.1 1.7 0.3 -3.1 -2.0
0.2 0.6 0.8 0.6 0.2 0.4 0.5 2.4 4.3 0.8 0.5 0.6
0.5 -0.6 -0.8 -0.5 -0.2 -0.1 -0.5 -2.4 -4.3 -0.8 -0.5 -0.6
0.0 0.0 0.0 0.0 6.7 0.1 0.4 9.9
2.5 0.2 0.0 15 6.5 6.7 0.1 0.4 -0.2 0.3 0.2
8.7 11 5.0 5.0 -0.1 -0.2 -0.5 -0.7 -11 -0.9 2.9
11 8.3 11 19 11 69 -0.1 65 -0.5 -11 -0.7 24
5.0 -3.1 -2.1 7.7 1.9 59 -15 42 -37 -26 -14 10
-7.0 -11 -13 -12 -9.5 -10 -15 -23 -36 -15 -14 -14

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?